Cargando…

Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features

OBJECTIVE: To investigate the value of contrast-enhanced computed tomography (CECT) radiomics features in predicting the efficacy of epirubicin combined with ifosfamide in patients with pulmonary metastases from soft tissue sarcoma. METHODS: A retrospective analysis of 51 patients with pulmonary met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Lei, Ma, Shu-Tao, Jiang, Xu, Zhang, Huan-Huan, Wang, Yan-Mei, Li, Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316811/ https://www.ncbi.nlm.nih.gov/pubmed/35883116 http://dx.doi.org/10.1186/s12880-022-00859-6

Ejemplares similares

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas
por: Long, Zuoyao, et al.
Publicado: (2023)

Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors
por: Hirbe, Angela C., et al.
Publicado: (2017)

VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
por: Moon, Ji Young, et al.
Publicado: (2017)

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group
por: Nielsen, Ole S., et al.
Publicado: (2000)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Predicting risk of metastases and recurrence in soft-tissue sarcomas via Radiomics and Formal Methods
por: Casale, Roberto, et al.
Publicado: (2023)

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma
por: Martin-Liberal, Juan, et al.
Publicado: (2013)

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
por: Verboom, Michiel C., et al.
Publicado: (2019)

MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma
por: Spraker, Matthew B., et al.
Publicado: (2019)

Correction to: Predicting risk of metastases and recurrence in soft-tissue sarcomas via Radiomics and Formal Methods
Publicado: (2023)

Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma
por: Liu, Ying, et al.
Publicado: (2023)

Outcome and Toxicity of an Ifosfamide-Based Soft Tissue Sarcoma Treatment Protocol in Children. The Importance of Local Therapy
por: Yule, S. Murray, et al.
Publicado: (1998)

Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
por: Savani, Malvi, et al.
Publicado: (2019)

A Phase II Study of Docetaxel and Epirubicin in Advanced Adult Soft Tissue Sarcomas (STS)
por: Kalofonos, Haralabos P., et al.
Publicado: (2004)

Correction: Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma
por: Liu, Ying, et al.
Publicado: (2023)

Sequential Dose-Dense Doxorubicin and Ifosfamide in Advanced Soft-Tissue Sarcoma Patients in an Out-Patient-Basis Schedule
por: Almeida, G. F. G., et al.
Publicado: (2011)

Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: a single-institution retrospective analysis
por: Saito, Shiro, et al.
Publicado: (2020)

Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study
por: Tian, Zhichao, et al.
Publicado: (2021)

The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report
por: Jiang, Lijun, et al.
Publicado: (2019)

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
por: Nielsen, O. S., et al.
Publicado: (1998)

Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy
por: Schenone, Aaron D, et al.
Publicado: (2014)

Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
por: Chen, Wen, et al.
Publicado: (2021)

Screening and surveillance CT abdomen/pelvis for metastases in patients with soft-tissue sarcoma of the extremity
por: Thompson, M. J., et al.
Publicado: (2015)

CT and MRI radiomics of bone and soft-tissue sarcomas: a systematic review of reproducibility and validation strategies
por: Gitto, Salvatore, et al.
Publicado: (2021)

Definitive radiotherapy and Single-Agent radiosensitizing Ifosfamide in Patients with localized, irresectable Soft Tissue Sarcoma: A retrospective analysis
por: Eckert, Franziska, et al.
Publicado: (2010)

Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients
por: Wang, Bing, et al.
Publicado: (2016)

Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor
por: Provenzano, Salvatore, et al.
Publicado: (2017)

Radiomics model based on contrast-enhanced CT texture features for pretreatment prediction of overall survival in esophageal neuroendocrine carcinoma
por: Zhou, Yue, et al.
Publicado: (2023)

Local Recurrence of Soft Tissue Sarcoma: A Radiomic Analysis
por: Tagliafico, Alberto Stefano, et al.
Publicado: (2019)

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma
por: Wang, Zhi‐Ming, et al.
Publicado: (2020)

Outcomes and computed tomography radiomic features extraction in soft tissue sarcomas treated with neoadjuvant radiation therapy
por: González-Viguera, Javier, et al.
Publicado: (2021)

Radiomic Features As Biomarkers of Soft Tissue Paediatric Sarcomas: Preliminary Results of a PET/MR Study
por: Giraudo, Chiara, et al.
Publicado: (2022)

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
por: Chawla, Sant P, et al.
Publicado: (2013)

Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis
por: Carter, Thomas J., et al.
Publicado: (2020)

Combination of ifosfamide and etoposide as a salvage regimen for previously treated soft tissue sarcomas: a retrospective single centre study
por: Ribeiro, Luiz Fernando, et al.
Publicado: (2022)

Pulmonary Metastases of Alveolar Soft-Part Sarcoma: CT Findings in Three Patients
por: Choi, Joon-Il, et al.
Publicado: (2000)

Tumor grading of soft tissue sarcomas using MRI-based radiomics
por: Peeken, Jan C., et al.
Publicado: (2019)

Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC
por: Chen, Lu, et al.
Publicado: (2022)

CT and MR imaging features of soft tissue rhabdoid tumor: compared with rhabdomyosarcoma in children
por: Sheng, Jing, et al.
Publicado: (2023)

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
por: Leyvraz, S, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_hm39no88snftrubsd8dasdo35s